Immunotherapy Current Events | Immunotherapy News | 3
|
|
|
Sort By:
Page Views | Date |
How Bacteria get into Brains to Cause Meningitis
An international collaboration between medical researchers may have identified how meningitis causing bacteria cross from the blood into the brain, paving the way for new strategies to prevent this fatal disease, the Society for General Microbiology's Spring Meeting in Edinburgh heard today, Tuesday 8 April 2003. "Almost every known bacteria... view more... (2003-04-02)
OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
Data from an ongoing study designed to explore the biologic and clinical activity of cancer immunotherapy sipuleucel-T, or Provenge, in patients with early stage recurrent prostate cancer who have a rising serum prostate specific antigen (PSA) level, but who have not yet developed metastatic disease will be presented by Oregon Health & Science... view more... (2007-06-04)
Cancer Research UK supports additional TroVax phase II trial in colorectal cancer
Oxford BioMedica announced today that Cancer Research UK (CRUK) has agreed to conduct and sponsor an open label Phase II trial with Oxford BioMedica's leading cancer immunotherapy product, TroVax®, in colorectal cancer patients who have liver metastases. The decision by CRUK follows extensive review of the successful Phase I/II data of TroVax... view more... (2003-08-28)
Scripps research scientists enhance immune system attacks on cancer
In an Early Edition issue of the Proceedings of the National Academy of Sciences (PNAS) published online on October 20, 2008, the scientists describe how they used multiple tactics to rev up both innate and adaptive immunity to enhance the body's ability to fight cancer. view more (2008-10-22)
Immunologists find better way to boost the immune system
Immunologists have discovered how to manipulate the immune system to increase its power and protect the body from successive viral infections. view more (2008-01-23)
Molecular studies in cancer of the colon
According to Dr. Jesús García-Foncillas, Director of the Department of Oncology at the University Hospital (University of Navarra), molecular studies in cancer of the colon will contribute to the establishment of more efficient and less toxic treatments. view more (2005-10-24)
Immune system activated in schizophrenia
Researchers at the Swedish medical university Karolinska Institutet have discovered that patients with recent-onset schizophrenia have higher levels of inflammatory substances in their brains. Their findings offer hope of being able to treat schizophrenia with drugs that affect the immune system. view more (2009-11-18)
Life-threatening lupus responds to stem cell transplant therapy
Transplanting patients with blood stem cells that originate from their own bone marrow can induce the remission of life-threatening, treatment-resistant lupus. view more (2006-02-01)
Arthritis drug might prove effective in fighting the flu, study suggests
Researchers at the University of Maryland School of Medicine have found that an approved drug for treating rheumatoid arthritis reduces severe illness and death in mice exposed to the Influenza A virus. view more (2009-05-27)
ENZYME CONCENTRATIONS AND SKIN DISEASE MAY PREDICT SEVERITY OF REACTIONS TO BEE AND WASP STINGS (p 361)
Raised concentrations of the enzyme tryptase, associated with previously undiagnosed skin disease, may be a predictor of how people will react to bee and wasp stings, reports a study in this week’s issue of THE LANCET. 5% of adults in Europe and the USA have anaphylactic (hypersensitive) reactions to bee and wasp stings. The severity of... view more... (2001-01-31)
Vaccine shows therapeutic promise against advanced melanoma
A vaccine for one of the most lethal cancers, advanced melanoma, has shown improved response rates and progression-free survival for patients when combined with the immunotherapy drug, Interleukin-2. view more (2009-06-01)
The Lancet Neurology - January 2003
STROKE IN THE 21st CENTURY In the first issue of 2003, TLN examines stroke epidemiology and stroke trials. In their review, Valery Feigin and co-authors provide an overview of population-based studies of incidence, prevalence, mortality, and case-fatality of stroke based on studies reported between 1996 and 2002. From their analysis the authors... view more... (2002-12-18)
EXPOSURE TO CATS CAN INDUCE ASTHMA TOLERANCE (p 752)
Children exposed to cat allergens at home can produce an immune response without developing asthma, report authors of a study in this week’s issue of THE LANCET. However, in some children, exposure to cat allergens remains the highest single risk factor for asthma. Although asthma is strongly associated with immediate hypersensitivity to... view more... (2001-03-07)
Immune system discovery could aid fight against TB
A key aspect of how the body kicks the immune system into action against tuberculosis is revealed in research published today. view more (2006-10-23)
New allergy vaccine provides long-lasting hay fever relief after just 6 weeks of shots
Researchers at The Johns Hopkins University School of Medicine have successfully used an experimental DNA-based vaccine to protect against ragweed allergies, commonly known as hay fever, after just six injections. view more (2006-10-05)
Newfound roadblock to interferon effectiveness against malignant melanoma
Researchers have uncovered a significant contributing factor to interferon resistance of malignant melanoma cells. view more (2005-09-22)
Scientists developing food allergy treatment
A team of scientists from across Europe are embarking on new research to develop a treatment for food allergy. view more (2008-12-01)
Protein may be linked to melanoma recurrence
Higher levels of a protein called S-100 in patients with melanoma may correlate with a higher risk of having the disease return. view more (2007-06-04)
Phase 3 Alzheimer's drug increases toxic beta amyloid in the brain -- but still provides benefits
New insights into how a Phase III Alzheimer's drug might work were among the advances in potential therapies targeting two abnormal brain proteins - beta amyloid and phosphorylated tau - that were reported today at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) in Vienna. view more (2009-07-15)
New treatment hope for prostate cancer
Scientists at Melbourne's Burnet Institute have developed a potential new treatment for patients with prostate cancer. An article, which described the invention, has recently been published in the prestigious international journal The Journal of Clinical Investigation. view more (2009-02-06)
|
|
|
|
Sort By:
Page Views | Date |
|
